BioLab Holdings launches EmeraNova to advance the future of tissue
BioLab Holdings, an Arizona-based medical technology company, announced today a new, larger mission with the launch of EmeraNova, a new corporate identity that reflects a broader ambition to advance tissue restoration…
A lab supplier is worth considering only when its paperwork, products and delivery practices hold up to scrutiny. For an Arizona biotech startup, a low price means little if a…
Suppose scientists find a genetic change that appears often in people with a serious disease. They also identify a drug that might block its effects. Why not give the drug…
The human body is an amazing machine that has the ability to heal itself. When we cut our finger, the skin joins together over time. When we break a bone,…
Scientific discovery has always depended on curiosity, creativity, and the ability to test ideas. While brilliant researchers remain at the heart of innovation, the resources available within modern laboratories have…
One unannounced inspection is all it takes to expose gaps in your lab data. Your strongest defense starts with standardizing data capture, using integrity-driven systems, and building audit trails into…
Abbott and Exact Sciences, which does research at TGen in the Phoenix Bioscience Core, today announced a definitive agreement for Abbott to acquire Exact Sciences, which will enable it to…
NeuroCatch Inc., a brain health technology company based out of British Columbia, announced today it will open its United States headquarters in Greater Phoenix at the Phoenix Bioscience Core (PBC).…
Mixing is vital in laboratories, whether for scientific applications or industrial functions. It’s the way we combine things and maintain reactions. How you stir things really changes how things turn…
A new blueprint for Arizona’s emerging bioscience ecosystem lays out a plan for the state to capitalize on more than two decades of momentum and become a nationally recognized leader…
Researchers from the Translational Genomics Research Institute (TGen), part of City of Hope, and the Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center have identified a potential biomarker for long COVID. If…
Efficiency in clinical research is no longer just a goal; it’s a necessity. As the demand for faster, more precise, and patient-centered treatments grows, traditional clinical trial models are being…